doxazosin
Generic: doxazosin
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
doxazosin
Generic Name
doxazosin
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
TABLET
Routes
Active Ingredients
doxazosin mesylate 4 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-927
Product ID
71610-927_3ab22051-bf7b-5122-e063-6294a90a4f64
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA019668
Listing Expiration
2026-12-31
Marketing Start
2023-01-18
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610927
Hyphenated Format
71610-927
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
doxazosin (source: ndc)
Generic Name
doxazosin (source: ndc)
Application Number
NDA019668 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
Packaging
- 60 TABLET in 1 BOTTLE (71610-927-53)
- 90 TABLET in 1 BOTTLE (71610-927-60)
- 180 TABLET in 1 BOTTLE (71610-927-80)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3ab22051-bf7b-5122-e063-6294a90a4f64", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197627"], "spl_set_id": ["3ab222b7-74cc-5343-e063-6294a90a9616"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-927-53)", "package_ndc": "71610-927-53", "marketing_start_date": "20250718"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-927-60)", "package_ndc": "71610-927-60", "marketing_start_date": "20250718"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-927-80)", "package_ndc": "71610-927-80", "marketing_start_date": "20250718"}], "brand_name": "Doxazosin", "product_id": "71610-927_3ab22051-bf7b-5122-e063-6294a90a4f64", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-927", "generic_name": "doxazosin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "NDA019668", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20230118", "listing_expiration_date": "20261231"}